$361 Million is the total value of Integral Health Asset Management, LLC's 71 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 61.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNC | Buy | CENTENE CORP DEL | $18,540,000 | +197.5% | 225,000 | +125.0% | 5.13% | +186.4% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $17,399,000 | +23.1% | 409,000 | +28.2% | 4.82% | +18.5% |
| CYTK | CYTOKINETICS INC | $14,814,000 | +27.5% | 325,000 | 0.0% | 4.10% | +22.8% | |
| PKI | Buy | PERKINELMER INC | $14,074,000 | +62.4% | 70,000 | +40.0% | 3.89% | +56.3% |
| MCK | New | MCKESSON CORP | $13,671,000 | – | 55,000 | +100.0% | 3.78% | – |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $13,518,000 | +40.6% | 300,000 | +30.4% | 3.74% | +35.3% |
| GMED | Buy | GLOBUS MED INCcl a | $12,996,000 | +13.1% | 180,000 | +20.0% | 3.60% | +8.8% |
| PFE | Sell | PFIZER INC | $11,810,000 | +9.8% | 200,000 | -20.0% | 3.27% | +5.7% |
| ANTM | ANTHEM INC | $11,589,000 | +24.3% | 25,000 | 0.0% | 3.21% | +19.7% | |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $10,087,000 | +68.2% | 120,000 | +33.3% | 2.79% | +61.9% |
| ABT | New | ABBOTT LABS | $9,852,000 | – | 70,000 | +100.0% | 2.73% | – |
| CVS | Sell | CVS HEALTH CORP | $8,769,000 | -31.1% | 85,000 | -43.3% | 2.43% | -33.7% |
| BIIB | New | BIOGEN INC | $8,397,000 | – | 35,000 | +100.0% | 2.32% | – |
| AMED | New | AMEDISYS INC | $8,094,000 | – | 50,000 | +100.0% | 2.24% | – |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $8,033,000 | -20.3% | 75,000 | -23.5% | 2.22% | -23.2% |
| FATE | Buy | FATE THERAPEUTICS INC | $7,606,000 | +35.1% | 130,000 | +36.8% | 2.10% | +30.0% |
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $7,284,000 | -55.2% | 120,000 | -52.9% | 2.02% | -56.9% |
| CCXI | Sell | CHEMOCENTRYX INC | $7,282,000 | +41.9% | 200,000 | -33.3% | 2.02% | +36.6% |
| RLAY | Buy | RELAY THERAPEUTICS INC | $6,910,000 | +56.5% | 225,000 | +60.7% | 1.91% | +50.7% |
| HRTX | Buy | HERON THERAPEUTICS INC | $6,848,000 | +56.2% | 750,000 | +82.9% | 1.90% | +50.4% |
| ABBV | Buy | ABBVIE INC | $6,770,000 | +79.3% | 50,000 | +42.9% | 1.87% | +72.6% |
| THC | New | TENET HEALTHCARE CORP | $6,535,000 | – | 80,000 | +100.0% | 1.81% | – |
| LH | New | LABORATORY CORP AMER HLDGS | $6,284,000 | – | 20,000 | +100.0% | 1.74% | – |
| NTLA | INTELLIA THERAPEUTICS INC | $5,912,000 | -11.9% | 50,000 | 0.0% | 1.64% | -15.1% | |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $5,830,000 | +47.1% | 45,000 | +28.6% | 1.61% | +41.6% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $5,825,000 | – | 100,000 | +100.0% | 1.61% | – |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $5,674,000 | -9.4% | 120,000 | -36.8% | 1.57% | -12.8% |
| ONEM | New | 1LIFE HEALTHCARE INC | $4,832,000 | – | 275,000 | +100.0% | 1.34% | – |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $4,708,000 | – | 40,000 | +100.0% | 1.30% | – |
| DNLI | Buy | DENALI THERAPEUTICS INC | $4,460,000 | +17.9% | 100,000 | +33.3% | 1.23% | +13.4% |
| GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $4,410,000 | – | 100,000 | +100.0% | 1.22% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $4,241,000 | +204.9% | 48,000 | +166.7% | 1.17% | +193.5% |
| SIBN | Buy | SI-BONE INC | $3,887,000 | +6.8% | 175,000 | +2.9% | 1.08% | +2.8% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $3,392,000 | -28.1% | 20,000 | -20.0% | 0.94% | -30.8% |
| AGL | Sell | AGILON HEALTH INC | $3,375,000 | -28.5% | 125,000 | -30.6% | 0.93% | -31.1% |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $3,315,000 | – | 50,000 | +100.0% | 0.92% | – |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $3,233,000 | -50.8% | 30,000 | -50.0% | 0.90% | -52.6% |
| ATRA | ATARA BIOTHERAPEUTICS INC | $3,152,000 | -12.0% | 200,000 | 0.0% | 0.87% | -15.3% | |
| MASI | New | MASIMO CORP | $2,928,000 | – | 10,000 | +100.0% | 0.81% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $2,908,000 | -12.7% | 200,000 | +8.1% | 0.80% | -15.9% |
| NVRO | Buy | NEVRO CORP | $2,837,000 | -18.7% | 35,000 | +16.7% | 0.78% | -21.8% |
| AVALO THERAPEUTICS INC | $2,763,000 | -22.0% | 1,625,000 | 0.0% | 0.76% | -24.9% | ||
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $2,716,000 | -22.9% | 103,000 | +194.3% | 0.75% | -25.7% |
| REPL | Buy | REPLIMUNE GROUP INC | $2,710,000 | +1.6% | 100,000 | +11.1% | 0.75% | -2.2% |
| New | BRIDGEBIO PHARMA INCcall | $2,502,000 | – | 150,000 | +100.0% | 0.69% | – | |
| RGNX | Buy | REGENXBIO INC | $2,453,000 | +6.4% | 75,000 | +36.4% | 0.68% | +2.4% |
| ARCT | Sell | ARCTURUS THERAPEUTICS HLDGS | $2,406,000 | -40.8% | 65,000 | -23.5% | 0.67% | -42.9% |
| ITOS | New | ITEOS THERAPEUTICS INC | $2,328,000 | – | 50,000 | +100.0% | 0.64% | – |
| INCY | New | INCYTE CORP | $2,202,000 | – | 30,000 | +100.0% | 0.61% | – |
| INSM | Sell | INSMED INC | $2,179,000 | -20.9% | 80,000 | -20.0% | 0.60% | -23.9% |
| MGNX | Sell | MACROGENICS INC | $2,087,000 | -37.7% | 130,000 | -18.8% | 0.58% | -40.0% |
| QURE | New | UNIQURE NV | $2,074,000 | – | 100,000 | +100.0% | 0.57% | – |
| KROS | New | KEROS THERAPEUTICS INC | $2,048,000 | – | 35,000 | +100.0% | 0.57% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $2,021,000 | -50.2% | 175,000 | -58.8% | 0.56% | -52.1% |
| IMGN | Sell | IMMUNOGEN INC | $1,855,000 | +9.1% | 250,000 | -16.7% | 0.51% | +4.9% |
| AKRO | AKERO THERAPEUTICS INC | $1,798,000 | -5.4% | 85,000 | 0.0% | 0.50% | -8.8% | |
| PTCT | Sell | PTC THERAPEUTICS INC | $1,792,000 | -50.4% | 45,000 | -53.7% | 0.50% | -52.3% |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $1,648,000 | – | 140,000 | +100.0% | 0.46% | – |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $1,595,000 | – | 100,000 | +100.0% | 0.44% | – |
| DTIL | Buy | PRECISION BIOSCIENCES INC | $1,295,000 | -10.3% | 175,000 | +40.0% | 0.36% | -13.7% |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $1,222,000 | – | 75,000 | +100.0% | 0.34% | – |
| KURA | Buy | KURA ONCOLOGY INC | $1,190,000 | +5.9% | 85,000 | +41.7% | 0.33% | +1.9% |
| ALKS | New | ALKERMES PLC | $1,163,000 | – | 50,000 | +100.0% | 0.32% | – |
| LYEL | LYELL IMMUNOPHARMA INC | $1,084,000 | -47.7% | 140,000 | 0.0% | 0.30% | -49.7% | |
| FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $1,067,000 | -23.3% | 75,000 | +25.0% | 0.30% | -26.2% |
| LXRX | Sell | LEXICON PHARMACEUTICALS INC | $788,000 | -53.2% | 200,000 | -42.9% | 0.22% | -55.0% |
| CMRX | Buy | CHIMERIX INC | $707,000 | +26.9% | 110,000 | +22.2% | 0.20% | +22.5% |
| AMRN | New | AMARIN CORP PLCspons adr new | $674,000 | – | 200,000 | +100.0% | 0.19% | – |
| MGTA | MAGENTA THERAPEUTICS INC | $399,000 | -39.1% | 90,000 | 0.0% | 0.11% | -41.5% | |
| MYOV | Sell | MYOVANT SCIENCES LTD | $389,000 | -73.3% | 25,000 | -61.5% | 0.11% | -74.2% |
| LBPH | LONGBOARD PHARMACEUTICALS IN | $146,000 | -45.1% | 30,000 | 0.0% | 0.04% | -47.4% | |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -35,000 | -100.0% | -0.18% | – |
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -20,000 | -100.0% | -0.26% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -30,000 | -100.0% | -0.30% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.40% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -50,000 | -100.0% | -0.42% | – |
| ZY | Exit | ZYMERGEN INC | $0 | – | -160,000 | -100.0% | -0.61% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -10,000 | -100.0% | -0.67% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -20,000 | -100.0% | -0.80% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -0.82% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -20,000 | -100.0% | -1.02% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -30,000 | -100.0% | -1.19% | – |
| NTRA | Exit | NATERA INC | $0 | – | -40,000 | -100.0% | -1.28% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -40,000 | -100.0% | -1.37% | – |
| LFST | Exit | LIFESTANCE HEALTH GROUP INC | $0 | – | -350,000 | -100.0% | -1.46% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -10,000 | -100.0% | -1.57% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -10,000 | -100.0% | -1.74% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -40,000 | -100.0% | -1.95% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -60,000 | -100.0% | -2.52% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -120,000 | -100.0% | -2.55% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -80,000 | -100.0% | -2.88% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -5.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.